“After examining different vessel quantification tools for use with neovessel formation in the heart, we chose to use Vesselucida 360 because it offered us flexibility in viewing and adjusting vessel geometries in 3D to accurately represent our microCT dataset. Also, the quantitative parameter extrapolation is excellent.”
“Vesselucida enables us to visualize and quantify microvascular networks in a way that has not been done before. The ability to render 3D maps is integral to analysis of network structure, remodeling and blood flow distribution.”
“Mapping microvascular networks are opening the door on novel aspects of microvascular perfusion. At this preliminary stage we are able to identify a fundamentally new perspective on oxygen transport. Very exciting to be developing this with you guys.”
“The support team at MBF Bioscience has been great to work with. As a beta test site for Vesselucida, we are in constant communication. Their staff is professional & responsive to the problems we have identified & our requests for specific applications.”
“Using Vesselucida, we were able to assess changes in resistance network architecture during muscle regeneration for the first time. We were limited by other imaging methods due to the network size and location of arteriolar networks within skeletal muscle. Vesselucida uniquely enabled us to reconstruct and analyze intact arteriolar networks in 3 dimensions with micrometer resolution over distances spanning millimeters to centimeters.”